This advertisement has not loaded yet, but your article continues below. BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralize the new Omicron…
The coronavirus vaccine developed jointly by BioNTech and Pfizer is “still effective” against the Omicron variant of the virus after three doses, the companies said in a statement on Wednesday. A…
The global Stem Cell Therapy market is expected to reach US$ 416.4 Million by 2027, with a CAGR of 18.2% from 2021 to 2027. Some of the primary drivers for the global stem cell therapy market are the rising frequency
Precision Business Insights published a research report on ‘Connected Injectable Drug Delivery Devices Market By Product (Connected Sensors and Integrated Connected Devices), By End user (Healthcare providers and Homecare Centers), By Technology (Bluetooth, NFC, and Others), and Geography – Global/Region/Country
Pulmonary drug delivery devices or systems include devices for delivering drugs through medical devices such as inhalers and nebulizers in patients with respiratory illnesses such as asthma. The devices are based on diverse delivery mechanisms and consist of types of
vTv Therapeutics has decided to chop down its workforce by almost two-thirds. The High Point, NC biotech announced Monday that it would pivot and now prioritize its lead program, the oral glucokinase…
Quebec-based Medicago and its adjuvant partner GlaxoSmithKline said Tuesday that their plant-based Covid-19 vaccine candidate proved to be 71% efficacious against all variants of SARS-CoV-2 in a Phase…
A new European biotech has put together a nearly $100 million Series A, and its lead program is going after a target recently validated by the FDA. Emergence Therapeutics raised €87 million in its…
Gary Glick is back at it again, founding yet another biotech company. And by the sheer size of its first raise, this may be the biggest one yet. Glick has assembled what he calls an all-star roster…
Even though many biopharma leaders have come together in recent years to address its gender gap, the consensus is clear: We still have a long way to go. Companies this year were 2.5 times more likely…
